Praxis Precision Medicines (PRAX) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$267.2 million.
- Praxis Precision Medicines' Enterprise Value rose 2517.28% to -$267.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$267.2 million, marking a year-over-year increase of 2517.28%. This contributed to the annual value of -$392.6 million for FY2024, which is 38286.22% down from last year.
- Praxis Precision Medicines' Enterprise Value amounted to -$267.2 million in Q3 2025, which was up 2517.28% from -$301.3 million recorded in Q2 2025.
- In the past 5 years, Praxis Precision Medicines' Enterprise Value ranged from a high of -$56.0 million in Q2 2022 and a low of -$392.6 million during Q4 2024
- In the last 4 years, Praxis Precision Medicines' Enterprise Value had a median value of -$124.3 million in 2023 and averaged -$190.1 million.
- Per our database at Business Quant, Praxis Precision Medicines' Enterprise Value crashed by 38286.22% in 2024 and then surged by 2517.28% in 2025.
- Praxis Precision Medicines' Enterprise Value (Quarter) stood at -$61.6 million in 2022, then tumbled by 31.95% to -$81.3 million in 2023, then tumbled by 382.86% to -$392.6 million in 2024, then surged by 31.95% to -$267.2 million in 2025.
- Its Enterprise Value was -$267.2 million in Q3 2025, compared to -$301.3 million in Q2 2025 and -$328.0 million in Q1 2025.